|
|
 Breast Cancer |
 |
|
|
|
|
|
| (Page 1 of 79) « Back | 1 | 2 | 3 | 4 | 5 | Next » |
»
Survival From Secondary Brain Tumors Correlated to Breast Cancer Subtypes
|
|
Screening breast cancers for three receptors could help doctors predict the likely survival of patients with brain metastases. A study published in the open access journal Breast Cancer Research shows that patients with tumours that are negative for estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth receptor-2 (HER2) or that are HER2+/ER- appear to be most at risk from developing brain metastases. Survival is also correlated to the triple receptor status.
|
»
Highly targeted therapies Against Hormone-dependent Breast Cancer
|
|
The identification of two cellular receptors that likely contribute to the genesis of hormone-dependent breast cancer points the way to new, highly targeted therapies against the disease, says a team led by scientists at Weill Cornell Medical College in New York City. The finding also helps explain how daily use of medicines such as aspirin might help keep these breast tumors at bay.
|
»
Gap in death rates from breast cancer between black and white women has increased
|
|
A new study from the American Cancer Society finds that while breast cancer death rates are decreasing for white women in every U.S. state, for African American women, death rates are either flat or rising in at least half the states. The study finds breast cancer death rates among African American women are decreasing in only 11 of 37 states with sufficient numbers for analysis and in the District of Columbia. In the rest, death rates are either flat (24 states) or actually increasing (two states: Arkansas and Mississippi).
|
»
New Test to Provide Better Care Of Breast Cancer Patients
|
|
A new test that examines large sections of the sentinel lymph node for genes expressed by breast cancer could reduce the risk of recurrence and multiple surgeries, doctors say.
|
»
Benefits of preventive measures for high-risk women with BRCA1 and BRCA2 mutations
|
|
The time has come for breast cancer risk assessment, counseling and genetic testing to move from cancer specialists to the realm of primary care, according to a presentation at the AAAS annual meeting, held this year in Boston.
|
|
| (Page 1 of 79) « Back | 1 | 2 | 3 | 4 | 5 | Next » |
|
